Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin Combination Therapy for MDR Gram-Negative Infections in Pediatric ICU
NCT04764058Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of colistin in Gram-negative bacterial infection, sponsored by Ain Shams University. Status: unknown.
02
Drugs
colistin
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on NCT04764058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04764058.